[Journal logo]

Volume 67 
Part 10 
Pages m1402-m1403  
October 2011  

Received 10 August 2011
Accepted 15 September 2011
Online 20 September 2011

[yk2019sup1]
[3d view]

[Cited in]
[Download citation]
Key indicators
Single-crystal X-ray study
T = 293 K
Mean [sigma](C-C) = 0.014 Å
Disorder in main residue
R = 0.035
wR = 0.084
Data-to-parameter ratio = 11.5
Details
Open access

2-(2-Pyridyl)pyridinium (2,2'-bipyridine-[kappa]2N,N')tetrakis(nitrato-[kappa]2O,O')bismuthate(III)

Zhao-Hui Menga* and Shu-Shen Zhanga

aCollege of Chemistry and Pharmacy Engineering, Nanyang Normal University, Nanyang 473061, People's Republic of China
Correspondence e-mail: nysymzh@126.com

The structure of the title compound, (C10H9N2)[Bi(NO3)4(C10H8N2)], consists of 2-(2-pyridyl)pyridinium cations and anions [Bi(NO3)4(C10H8N2)]-. The Bi3+ ion lies on the twofold axis. It is coordinated by two nitrogen atoms from one 2,2'-bipyridine ligand and eight oxygen atoms from four NO3- anions. The disordered cation is positioned at the inversion centre. The [Bi(NO3)4(C10H8N2)]- anions and 2-(2-pyridyl)pyridinium cations are connected via N-H...O hydrogen bonds into chains. Moreover, these chains are further linked into a two-dimensional layered structure through [pi]-[pi] stacking interactions between bipyridine ligands along the c axis [centroid-centroid distance = 2.868 (4) Å].

Related literature

For potential applications of bismuth(III) coordination compounds in medical chemistry, see: Sun & Szeto (2003[Sun, H. Z. & Szeto, K. Y. (2003). J. Inorg. Biochem. 94, 114-120.]); Sun et al. (2004[Sun, H. Z., Zhang, L. & Szeto, K. Y. (2004). Met. Ions Biol. Syst. 41, 333-378.]). For reported bismuth(III) coordination compounds, see: Andrews et al. (2006[Andrews, P. C., Deacon, G. B., Junk, P. C., Kumar, I. & Silberstein, M. (2006). Dalton Trans. pp. 4852-4858.]); Boitrel et al. (2003[Boitrel, B., Halime, Z., Michaudet, L., Lachkar, M. & Toupet, L. (2003). Chem. Commun. pp. 2670-2671.]); Marsh (2002[Marsh, R. E. (2002). Acta Cryst. B58, 893-899.]); Wullens et al. (1998[Wullens, H., Devillers, M., Tinant, B. & Declercq, J.-P. (1998). Acta Cryst. C54, 770-773.]); Yang et al. (2006[Yang, J.-Y., Fu, Y.-L., Chu, J. & Ng, S. W. (2006). Acta Cryst. E62, m2310-m2312.], 2007[Yang, N., Tanner, J. A., Wang, Z., Huang, J. D., Zheng, B. J., Zhu, N. Y. & Sun, H. Z. (2007). Chem. Commun. pp. 4413-4415.]). For the structure of disordered protonated 2,2'-bipyridine, see: Bowmaker et al. (1998[Bowmaker, G. A., Junk, P. C., Lee, A. M., Skelton, B. W. & White, A. H. (1998). Aust. J. Chem. 51, 293-309.]). For the bond-strength calculations, see: Brown & Altermatt (1985[Brown, I. D. & Altermatt, D. (1985). Acta Cryst. B41, 244-247.]); Brese & O'Keeffe (1991[Brese, N. E. & O'Keeffe, M. (1991). Acta Cryst. B47, 192-197.]).

[Scheme 1]

Experimental

Crystal data

  • (C10H9N2)[Bi(NO3)4(C10H8N2)]

  • Mr = 770.40

  • Monoclinic, C 2/c

  • a = 14.711 (5) Å

  • b = 10.169 (3) Å

  • c = 16.832 (5) Å

  • [beta] = 97.275 (6)°

  • V = 2497.7 (13) Å3

  • Z = 4

  • Mo K[alpha] radiation

  • [mu] = 7.14 mm-1

  • T = 293 K

  • 0.26 × 0.24 × 0.18 mm
Data collection

  • Bruker APEXII CCD diffractometer

  • Absorption correction: multi-scan (SADABS; Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]) Tmin = 0.258, Tmax = 0.360

  • 5998 measured reflections

  • 2224 independent reflections

  • 1895 reflections with I > 2[sigma](I)

  • Rint = 0.036
Refinement

  • R[F2 > 2[sigma](F2)] = 0.035

  • wR(F2) = 0.084

  • S = 1.02

  • 2224 reflections

  • 194 parameters

  • 11 restraints

  • H atoms treated by a mixture of independent and constrained refinement

  • [Delta][rho]max = 1.13 e Å-3

  • [Delta][rho]min = -1.43 e Å-3

Table 1
Selected bond lengths (Å)

Bi1-N3 2.444 (5)
Bi1-O5 2.470 (6)
Bi1-O2 2.564 (6)
Bi1-O4 2.626 (6)
Bi1-O1 2.703 (8)

Table 2
Hydrogen-bond geometry (Å, °)

D-H...A D-H H...A D...A D-H...A
N4-H7...O4 0.93 2.31 3.145 (10) 149

Data collection: APEX2 (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); cell refinement: SAINT (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); data reduction: SAINT; program(s) used to solve structure: SHELXS97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); program(s) used to refine structure: SHELXL97 (Sheldrick, 2008[Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.]); molecular graphics: SHELXTL (Bruker, 2008[Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.]); software used to prepare material for publication: SHELXTL.

Supplementary data and figures for this paper are available from the IUCr electronic archives (Reference: YK2019 ).

References

Andrews, P. C., Deacon, G. B., Junk, P. C., Kumar, I. & Silberstein, M. (2006). Dalton Trans. pp. 4852-4858.  [CSD] [CrossRef]
Boitrel, B., Halime, Z., Michaudet, L., Lachkar, M. & Toupet, L. (2003). Chem. Commun. pp. 2670-2671.  [CSD] [CrossRef]
Bowmaker, G. A., Junk, P. C., Lee, A. M., Skelton, B. W. & White, A. H. (1998). Aust. J. Chem. 51, 293-309.  [ISI] [CrossRef] [ChemPort]
Brese, N. E. & O'Keeffe, M. (1991). Acta Cryst. B47, 192-197.  [CrossRef] [ISI] [details]
Brown, I. D. & Altermatt, D. (1985). Acta Cryst. B41, 244-247.  [CrossRef] [ISI] [details]
Bruker (2008). APEX2, SAINT and SADABS. Bruker AXS Inc., Madison, Wisconsin, USA.
Marsh, R. E. (2002). Acta Cryst. B58, 893-899.  [CrossRef] [details]
Sheldrick, G. M. (2008). Acta Cryst. A64, 112-122.  [CrossRef] [details]
Sun, H. Z. & Szeto, K. Y. (2003). J. Inorg. Biochem. 94, 114-120.  [ISI] [CrossRef] [ChemPort]
Sun, H. Z., Zhang, L. & Szeto, K. Y. (2004). Met. Ions Biol. Syst. 41, 333-378.  [ChemPort]
Wullens, H., Devillers, M., Tinant, B. & Declercq, J.-P. (1998). Acta Cryst. C54, 770-773.  [CrossRef] [details]
Yang, J.-Y., Fu, Y.-L., Chu, J. & Ng, S. W. (2006). Acta Cryst. E62, m2310-m2312.  [CSD] [CrossRef] [details]
Yang, N., Tanner, J. A., Wang, Z., Huang, J. D., Zheng, B. J., Zhu, N. Y. & Sun, H. Z. (2007). Chem. Commun. pp. 4413-4415.  [CSD] [CrossRef]

Acta Cryst (2011). E67, m1402-m1403   [ doi:10.1107/S160053681103769X ]

This is an open-access article distributed under the terms of the Creative Commons Attribution Licence, which permits unrestricted use, distribution, and reproduction in any medium, provided the original authors and source are cited.